Stock Earnings

Question 1

What are Clarity Pharmaceuticals Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Clarity Pharmaceuticals Ltd has a total asset of $101, Net loss of $-64

Question 2

What are the key financial ratios for CLRPF?

Accepted Answer

Clarity Pharmaceuticals Ltd's Current ratio is 10.1, has a Net margin is 0, sales per share of $0.

Question 3

How is Clarity Pharmaceuticals Ltd's revenue broken down by segment or geography?

Accepted Answer

Currently Clarity Pharmaceuticals Ltd data is not available.

Question 4

Is Clarity Pharmaceuticals Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Clarity Pharmaceuticals Ltd has a net loss of $-64

Question 5

Does Clarity Pharmaceuticals Ltd have any liabilities?

Accepted Answer

yes, Clarity Pharmaceuticals Ltd has liability of 10

Question 6

How many outstanding shares for Clarity Pharmaceuticals Ltd?

Accepted Answer

Clarity Pharmaceuticals Ltd has a total outstanding shares of 321.47

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	0	0	0	11	6	3
Revenue Growth (YoY)	-100%	--	-100%	83%	100%	50%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	11	10	4	11	3
Research & Development	66	66	45	31	18	9
Operating Expenses	69	69	44	26	23	10
Other Non Operating Income (Expenses)	--	--	--	--	0	0
Pretax Income	-63	-63	-42	-24	-23	-10
Income Tax Expense	0	0	0	0	0	0
Net Income	-64	-64	-42	-24	-23	-10
Net Income Growth	52%	52%	75%	4%	130%	67%
Shares Outstanding (Diluted)	321.23	319.19	273.15	260.41	248.46	256.92
Shares Change (YoY)	13%	17%	5%	5%	-3%	0%
EPS (Diluted)	-0.2	-0.2	-0.15	-0.09	-0.09	-0.03
EPS Growth	31%	30%	64%	-1%	140%	46%
Free Cash Flow	-54	-54	-43	-27	-13	-7
Free Cash Flow Per Share	-0.16	-0.16	-0.15	-0.1	-0.05	-0.02
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-236.36%	-383.33%	-333.33%
Profit Margin	0%	0%	0%	-218.18%	-383.33%	-333.33%
Free Cash Flow Margin	0%	0%	0%	-245.45%	-216.66%	-233.33%
EBITDA	-69	-69	-44	--	-23	-10
EBITDA Margin	0%	0%	0%	--	-383.33%	-333.33%
D&A For EBITDA	0	0	0	--	0	0
EBIT	-69	-69	-44	-26	-23	-10
EBIT Margin	0%	0%	0%	-236.36%	-383.33%	-333.33%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Clarity Pharmaceuticals Ltd (CLRPF) Price